Cruikshank Mary, Eunson Paul
Senior House Officer, Department of Paediatric Neurosciences, Royal Hospital for Sick Children, Edinburgh, UK.
Dev Med Child Neurol. 2007 Aug;49(8):626-8. doi: 10.1111/j.1469-8749.2007.00626.x.
Intrathecal baclofen is used in the management of spasticity associated with cerebral palsy (CP). Sudden cessation of intrathecal baclofen may give rise to the potentially life-threatening baclofen withdrawal syndrome. We report three cases in which intravenous diazepam is used effectively in the management of planned intrathecal withdrawal. All three patients had CP. In the first patient, a 19-year-old male with quadriplegia, the intrathecal catheter had to be removed. The other two patients, an 11-year-old female with diplegia and a 16-year-old male with quadriplegia, both required the entire device to be removed. The purpose of this case report is to illustrate the potential management for elective cases in a similar situation.
鞘内注射巴氯芬用于治疗与脑瘫(CP)相关的痉挛。鞘内注射巴氯芬突然中断可能会引发有潜在生命危险的巴氯芬戒断综合征。我们报告了3例静脉注射地西泮有效用于计划性鞘内撤药管理的病例。所有3例患者均患有脑瘫。首例患者为一名19岁四肢瘫痪男性,必须移除鞘内导管。另外两名患者,一名11岁双瘫女性和一名16岁四肢瘫痪男性,均需要移除整个装置。本病例报告的目的是阐述类似情况下择期病例的潜在管理方法。